Lataa...
Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
The addition of sildenafil to nintedanib treatment does not improve outcomes to a greater extent than monotherapy with nintedanib, and it is not recommended for IPF subjects http://ow.ly/Gaq530o9kEg
Tallennettuna:
| Julkaisussa: | Breathe (Sheff) |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
European Respiratory Society
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6544796/ https://ncbi.nlm.nih.gov/pubmed/31191729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.0016-2019 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|